Approval · Notice of Compliance 1838 · 1999
COPAXONE: Notice of Compliance 1838
Issued March 16, 1999
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 1838
- Date
- March 16, 1999
- Company
- Teva Pharmaceuticals Usa
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Product monograph revisions
- Therapeutic class
- Immunomodulator
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| COPAXONE | Not yet assigned | — |
Medicinal ingredients
- GLATIRAMER ACETATE 20 MG per ML